Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and, as Zepbound, for weight management
Independent pharmacology analyses that examined a batch of roughly two dozen topically marketed weight loss products found that none of them listed an FDA approved GLP-1 medicine such as semaglutide or tirzepatide as an active ingredient
Brief exposure to room temperature (a few hours during travel with an insulated case) is generally safe, but semaglutide should not be stored above 46F for extended periods
Side Effects by Medication Understand how different weight loss solutions affect your body, from digestive discomfort to hormonal shifts, and know what to expect before you start
Weight Loss in Clinical Trials Researchers randomly assigned participants to take a daily pill containing 25 mg of semaglutide or a placebo
As noted by experts at the University of Connecticut, GLP-1 peptide molecules are too large to effectively penetrate the skin barrier, making transdermal delivery of actual GLP-1 medications currently impossible with existing technology